DuPont (NYSE: DD) today announced it has received a perfect score of 100 on the Human Rights Campaign Foundation's 2025 Corporate Equality Index (CEI), the nation's foremost benchmarking survey and ...

This was the stock's third consecutive day of losses.

DuPont de Nemours Inc. closed $14.98 short of its 52-week high ($90.06), which the company achieved on September 27th.

Nemours Children’s Health plans to expand its pediatric hospital and develop two new facilities on its Lake Nona campus, spending $300 million in Central Florida during the next four years, the ...

Nemours said it is the pediatric health system's largest one-year capital investment in Delaware in its 85-year history. Nemours Children's Health unveiled plans Tuesday to invest $130 million at ...

Nemours hospital helps Orlando baby born at 24 weeks beat the odds 40% chance of survival: Nemours helps baby born at 24 weeks beat odds Read full article: 40% chance of survival: Nemours helps ...

Argus keeps a Buy rating and $85 price target on DuPont (DD) while noting that the stock’s recent weakness is offering a buying opportunity.

(Editor's note: This story has been updated to include comment from Nemours Children's Health and reflect where the retracted articles were originally published.) A former researcher at Nemours ...

Jefferies analyst Laurence Alexander maintained a Buy rating on DuPont de Nemours (DD – Research Report) today and set a price target of $116.00. The company’s shares closed last Friday at $80.84.

Nemours Children's Health will invest $130 million next year to expand its Advanced Delivery Program and Neonatal Intensive Care Unit, as well as renovate the original Alfred I. duPont Institute ...

Growth in specialty programs, preservation of historic Alfred I. duPont Institute building underscore Nemours Children's continued commitment to Delaware andthe health of its children WILMINGTON, Del.

Obvious causes like appendicitis and gallbladder problems were ruled out. Finding the solution meant asking an embarrassing ...